GT Biopharma Reports First Quarter 2026 Financial Results

Go back to GT Biopharma Reports First Quarter 2026 Financial Results
(NASDAQ: GTBP) Delayed: 0.51 +0.05 (10.87%)
Previous Close $0.46    52 Week High
Open $0.48    52 Week Low
Day High $0.51    P/E N/A 
Day Low $0.45    EPS
Volume 1,977,634